JAK2 and non-small cell lung carcinoma: For example, the upregulation of FGF signaling is found to be a critical mechanism in which the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway mediates tumor angiogenesis in NSCLC [105,106].